Molecular and Structural Comparison of Hypospadic and Normal Children Prepuces

April 25, 2020 updated by: Irem Inanc, Trakya University

Comparison of Structural and Molecular Genetic Properties Between Normal and Hypospadic Children's Prepuces

The aim of this study is to compare prepuce tissue samples from healthy male children who applied for circumcision and children with isolated hypospadias. Estrogen receptor 1 (ER1), androgen receptor (AR), FGFR2, transforming growth factor beta (TGF beta) and HOXA13 gene expression in the prepuce is planned to investigate via polymerase chain reaction (PCR) method. Mucosal vascular and nerve densities, and extracellular matrix density of laminin and collagen protein is planned to investigate via immunohistochemical examination.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

52

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Edirne, Turkey, 22030
        • Trakya University Faculty of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

0-18 years old pediatric male population, patients with isolated hypospadias are study group, patients with planned circumcision are control group.

Description

Inclusion Criteria:

  • To apply for circumcision, not to have any genitourinary abnormalities/conditions for control group.
  • To have isolated hypospadias for study group.

Exclusion Criteria:

  • To have genitourinary surgery before.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Study
Children with isolated hypospadias
Control
Children with planned circumcision

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Genetic analysis 1
Time Frame: 1 year
Androgen receptor (AR) gene PCR analysis
1 year
Genetic analysis 2
Time Frame: 1 year
Estrogen receptor 1 (ER1) gene PCR analysis
1 year
Genetic analysis 3
Time Frame: 1 year
FGFR2 gene PCR analysis
1 year
Genetic analysis 4
Time Frame: 1 year
TGF beta gene PCR analysis
1 year
Genetic analysis 5
Time Frame: 1 year
HOXA13 gene PCR analysis
1 year
Immunohistochemical study 1
Time Frame: 1 year
Mucosal vessel density is planned to determine via CD34
1 year
Immunohistochemical study 2
Time Frame: 1 year
Mucosal nerve density is planned to determine via PGP 9.5
1 year
Histological study 1
Time Frame: 1 year
Laminin is planned to determine in extracellular matrix via light microscope
1 year
Histological study 2
Time Frame: 1 year
Collagen is planned to determine in extracellular matrix via light microscope
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dincer Avlan, Profesor, MD, Trakya University Faculty of Medicine, Pediatric Surgery Department

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 7, 2019

Primary Completion (Actual)

January 7, 2020

Study Completion (Actual)

March 10, 2020

Study Registration Dates

First Submitted

February 8, 2019

First Submitted That Met QC Criteria

February 9, 2019

First Posted (Actual)

February 12, 2019

Study Record Updates

Last Update Posted (Actual)

April 28, 2020

Last Update Submitted That Met QC Criteria

April 25, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Hypospadic prepuce structure

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe